Julie Rubinstein, President at Adaptive Biotechnologies Corp (ADPT), sold 64,650 shares at $3.43 ($224K) on 2024-03-05, disclosed to the SEC on 2024-03-06.
Seasonal sale ($224k) by President — this insider has traded ADPT in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.43 | 25,580 | $88K | 39.3% |
| 2 | $3.43 | 25,580 | $88K | 39.3% |
| 3 | $3.56 | 13,490 | $48K | 21.5% |
| Total | $3.46 avg | 64,650 | $224K | 100% |
| Filing → |
| ADPT | SELL | 2026-10-05 | $1.0M | — | Filing → |
| ADPT | SELL | 2026-04-29 | $271K | — | Filing → |
| ADPT | SELL | 2026-04-24 | $798K | — | Filing → |